Search
Johnson & Johnson

CATALENT CTS

Featured products of Catalent CTS
Imbruvica
Imbruvica cap 140 mg
ibrutinib
Packing/Price
120's90's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Distributed by Johnson & Johnson
Imbruvica
Imbruvica cap 140 mg
ibrutinib
Packing/Price
120's90's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL01 - ibrutinib : Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in